Summary
Introduction
Obesity is an established risk factor for cardiovascular disease including acute cerebrovascular disease -acute ischemic and haemorrhagic strokes (1) . Links between obesity and stroke are well-established (1) . Stroke is the fifth leading cause of death in the United States and constitutes a leading cause of chronic disability. Conversely, several reports show that obesity is associated with better outcomes following several acute conditions -heart failure, carotid endarterectomy, sepsis, bypass surgery and vascular surgery (2) (3) (4) (5) . Similar reports of better outcomes in patients with obesity following ischemic and haemorrhagic strokes in the literature remain controversial (6) (7) (8) (9) (10) . The debates surrounding the concept of obesity paradox in 'stroke' include factors such as definition, classification and duration of obesity and the influence of race and racial diversity in obesity (11, 12) . Of these, race is the most poorly understood.
Compared with White populations, the AfricanAmerican populations of the United States have a higher incidence of obesity and are more likely to have worse outcomes (13) . Obesity along with several other factors likely play a role in outcome differences between races following acute stroke (14, 15) . However, it remains unclear if outcomes will differ in patients with obesity of different races following an acute intracerebral haemorrhage (ICH).
Several studies have explored outcomes of patients with obesity following ischemic stroke in the literature (7, 11, 12) . Nonetheless, studies on the outcomes of patients with obesity following ICH are limited (10) . Second, most reports on obesity paradox in 'stroke' do not account for racial diversity in their study. One study from South Korea on outcome of obese patients following spontaneous ICH primarily represents patients of Asian descent (10) . Thus, a study within the stroke belt of the United States with a racially diverse population was conducted to determine and compare the outcomes of patients with obesity following ICH among White and non-White populations. This study explores the hypothesis that outcomes will differ between White and nonWhite patients with obesity following acute ICH.
Methods
The Get with the guideline-Stroke database was queried for all patients admitted to Ochsner Medical Center, New Orleans, LA; during the period 1 November 2012 to 31 March 2016. The Get with the guideline-Stroke database is a mandated database of all acute stroke patients by the Joint Commission on Accreditation of Healthcare Organizations presenting to primary and comprehensive certified stroke centres in the United States. All patients admitted with a diagnosis of ICH were identified for inclusion in the study. Inclusion criteria were age ≥18 years, symptom onset within 24 h and ICH confirmed on computed tomography (CT) or magnetic resonance imaging. Exclusion criteria included patients with prior admissions for ICH, haemorrhagic conversion of ischemic strokes, traumatic brain injury, primary or secondary brain malignancy, post-operative intracranial haemorrhages, vascular malformations and venous sinus thrombosis.
Data on demographics, medical history, clinical, laboratory, imaging characteristics and discharge disposition were collected.
• Imaging -All neuroimaging studies of all patients for initial and follow up CT studies were reviewed. Routinely, a follow-up head CT is obtained at 6-h intervals until hematoma size is stable and/or at 18-24 h. Data on hematoma volume, location and the presence of intraventricular haemorrhage with Graeb scores were collected. ICH volume was calculated using the ABC/2 formula, a previously validated formula for estimating hematoma volume (16) . The Graeb score is a 12-point scale based on gross haemorrhage size and dilatation of the ventricles, higher scores representing worse intraventricular haemorrhage (17) . Hematoma location was classified as Deep (thalamic and basal ganglia) nuclei, cerebellum, brainstem and lobar. Hematoma expansion is defined as an increase in hematoma volume by ≥30% on follow up 24 h neuroimaging.
• Discharge disposition -All records of discharge locations were reviewed and documented as (1) home with self-care or outpatient therapy; (2) ICH location were significantly different between the groups ( Table 2) .
As expected, logistic analysis demonstrated age (Estimate 0.027 SE 0.009 p = 0.0027), ICH location (Estimate 1.456 SE 0.488 p = 0.0031), and ICH volume (Estimate 0.035 SE 0.005 p = <0.0001) as independent predictors of poor disposition outcomes. In addition, there was a significant effect of normal BMI category on poor disposition outcomes (Estimate À0.574 SE 0.919 p = 0.0112). Only age (Estimate À0.024 SE 0.011 p = 0.029) and hypertension (Estimate 1.048 SE 0.406 p = 0.01) were independent predictors of hematoma expansion outcome (Table 3) . Subsequently, data analyses were adjusted for age, hypertension, DM, CHF, blood pressure and ICH volume, and differences in odds ratios for poor outcomes in BMI category were determined. Results demonstrated that patients with obesity were significantly more likely to have a poor disposition outcome as compared with both normal and overweight subjects -Normal vs. Obese OR 0.26 CI 0.115-0.593 p = 0.0014; Obese vs. Overweight OR 3.79 CI 1.68-8.52 p = 0.0013 (Table 4) .
Overall, race did not influence disposition or hematoma expansion (>30% increase in ICH volume) outcomes. However, within the non-White population, the obese category (BMI 30 -<34.9 kg/m 2 ) had higher odds of a poor disposition outcome than normal weight (OR 6.84 CI 2.12-22.22 p = 0.0013) and overweight categories (OR 8.45 CI 2.6-27.49 p = 0.0004). Similar odds were not observed in other BMI category comparisons in the nonWhite population or in any BMI category in the White population (Table 5 ).
Discussion
The obesity paradox was not detected in this ICH cohort. On the contrary, obesity was associated with poor disposition outcomes. However, no relationship between obesity and 24-h hematoma expansion was observed. Additionally, although race did not influence overall study results, within the non-White population obesity was associated with poor hospital discharge disposition outcome, a result that was not observed in patients with normal weight and overweight. Interestingly, this observation was not detected in the White population group. The vast majority of studies on obesity and ICH outcomes have focused primarily on ischemic stroke, and in some, in combination with haemorrhagic strokes (6, 7, 9, (11) (12) (13) . A single study on obesity and ICH outcomes was predominantly composed of an Asian population (10) .In this study, the non-White population were predominantly African American (89.1%); hence, the findings may only be applicable to the White population and populations of African descent. The difference in outcomes when comparisons were performed within each race group was unexpected. C-reactive protein and IL-6 are inflammatory markers that have been widely studied. Several studies demonstrated higher markers of inflammation in 'Blacks' compared with White populations. However, adjusting for socio-demographic and vascular risk factors (including obesity) attenuated the difference in inflammatory markers (21, 22) . This is not surprising, since obesity is associated with a chronic low-grade inflammation due to release of cytokines from adipocytes (23) . Despite the known differences in inflammatory markers in patients with and without obesity (24) , it is unknown if similar differences exist in White vs. non-White patients with obesity or between patients with obesity and normal weight patients within each race group.
Based on this study, a postulation is that obesity in nonWhites likely has a higher detrimental impact on outcomes following ICH compared with the White population.
As previously reported, the timing of measured outcomes following an index acute illness influences study results (11, 12) . Dehlendorff et al. reported the absence of an obesity paradox after stroke if the outcomes were measured within 1 week or 1 month of acute stroke (12) . However, this study included patients with both ischemic and haemorrhagic strokes and was conducted in a predominantly White Scandinavian population. In this study, the primary outcomes measured are directly related to acute ICH (disposition at hospital discharge and hematoma expansion >30%). Similar to previous reports on outcomes close to the ictus, no obesity paradox on outcomes following ICH was observed at the time of hospital discharge.
Studies on obesity and acute illness are frequently fraught with methodological limitations in measuring obesity. It is well described that waist circumference and waist-hip ratio are more reflective and sensitive in predicting outcomes than BMI (25) . ICH is an acute illness and in most cases, patients are critically ill which likely precludes detailed anthropometric measurements. In this study, we classified patients with Classes II and III obesity separately as 'severe obesity' (BMI >35.0 kg/m 2 ). Previous studies have shown that BMI >35.0 kg/m 2 correlates with higher waist circumference above cut off predictive values (1, 26) . However, after adjusting for cofounding variables such as age, DM and hypertension, there was no difference in outcomes. The possibility that the relative younger age in this group likely impacted on the aggressiveness of clinical management in the study cohort cannot be excluded. This study has several strengths. This is the first report on the role of obesity on ICH outcomes with a relatively high number of African Americans. Second, this study separated the severe obese category (>35.0 kg/m 2 ) who historically are known to carry a higher risk for cardiovascular disease. Third, selected outcomes (hematoma expansion >30% and hospital disposition) reflect the primary disease process, ICH. However, there are limitations to the results of this study. Despite the relative large sample size, the retrospective nature of our study renders our conclusions observational. Poor records limited detailed analysis of some variables -images from patients referred to our institution to compare ICH volume changes, time of symptom onset and last known normal.
Second, prior studies have demonstrated the superiority of other anthropometric measurements over BMI, such as waist circumference, waist-hip ratio and body fat by dual-energy X-ray absorptiometry. In this study cohort, these measurements were not routinely obtained and are limited by the acuity of the patients particularly due to critically raised intracranial pressure, cerebral edema with or without brain herniation at presentation. Third, despite adjusting for premorbid conditions such as hypertension, CHF and DM, the severity of these premorbid conditions using tools such as the Charlson comorbidity index was not available in the study and not measured. Hence, the ability to independently ascribe ICH outcomes to the presence of obesity alone is limited. Due to the retrospective nature of the study, the methods of obtaining height measurements by the nursing staff may be limited by factors such as patient acuity on presentation and ongoing resuscitative efforts. Lastly, the non-inclusion of the 73 (17%) patients without a follow up CT head for the outcome analysis of hematoma expansion may have created a selection bias. However, to further minimize the effect of selection bias on outcomes, they were included in the disposition outcome analysis report while the analysis excluding these patients (not reported) obtained similar results. Regardless of these limitations, the findings are unique and illustrate the need to further examine the role of excess adiposity and race on ICH acute outcomes.
In conclusion, this study did not detect an obesity paradox following ICH. Conversely, obesity was associated with poor disposition outcomes following ICH particularly in the non-White, but not White population. Finally, neither obesity nor race influenced hematoma expansion. Prospective research is needed to examine the role of excess adiposity and race on both acute and long-term health outcomes following ICH.
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